Get access

Anti-adipogenic effect of PDGF is reversed by PKC inhibition

Authors

  • Y. Artemenko,

    1. Ottawa Health Research Institute, Department of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada
    Search for more papers by this author
  • A. Gagnon,

    1. Ottawa Health Research Institute, Department of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada
    Search for more papers by this author
  • D. Aubin,

    1. Ottawa Health Research Institute, Department of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada
    Search for more papers by this author
  • A. Sorisky

    Corresponding author
    1. Ottawa Health Research Institute, Department of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Ontario, Canada
    • Ottawa Health Research Institute, 725 Parkdale Avenue, Ottawa, Ontario, K1Y 4E9, Canada.
    Search for more papers by this author

Abstract

Healthy adipose tissue function depends on adipogenesis. The capacity to form new adipocytes prevents the emergence of insulin-resistant hypertrophied adipocytes, as well as the deleterious lipid deposition in muscle, liver, and pancreas. It is therefore important to understand how adipogenesis is modulated. Platelet-derived growth factor (PDGF) is anti-adipogenic, but the stage of differentiation that it targets, and the signaling pathways that it triggers, are not defined. We have studied the inhibitory effect of PDGF on murine 3T3-L1 preadipocyte and human preadipocyte differentiation. There was a significant attenuation in the protein expression of the adipogenic transcription factors, PPARγ and C/EBPα, as well as in the levels of later differentiation markers, including adiponectin, aP2, and fatty acid synthase. PDGF treatment resulted in the persistence of PDGF receptor and PKCα expression, in contrast to the expected downregulation of both proteins that occurs during differentiation. Inactivation of conventional PKC isoforms, by bisindolylmaleimide I or PKC pseudosubstrate M20–28, partially reversed the inhibition of 3T3-L1 and human preadipocyte differentiation by PDGF, as assessed by fatty acid synthase expression and morphological appearance. © 2005 Wiley-Liss, Inc.

Get access to the full text of this article

Ancillary